Dec 1 (Reuters) – The top executives at two of the largest
U.S. drugmakers weighed in on Thursday for the first time on
possible changes for the industry next year under U.S.
President-elect Donald…
The post UPDATE 1-Pharma execs weigh in on possible changes under Trump appeared first on NASDAQ.